{"gene":"KCNAB2","run_date":"2026-04-28T18:06:54","timeline":{"discoveries":[{"year":1994,"finding":"Kvβ2 (KCNAB2) belongs to the NAD(P)H-dependent oxidoreductase (aldo-keto reductase, AKR) superfamily, establishing that the beta subunit core domain has structural homology to oxidoreductases.","method":"Sequence analysis and structural homology","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — foundational sequence/structural analysis, highly cited, widely accepted","pmids":["8001150"],"is_preprint":false},{"year":1995,"finding":"Kvβ2 (KCNAB2) modulates the inactivation properties of Kv1.4 alpha subunits in functional expression assays, demonstrating a direct electrophysiological role for the beta 2 subunit.","method":"Heterologous expression and electrophysiology","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 1 — direct functional electrophysiology in expression system, replicated in subsequent studies","pmids":["7649300"],"is_preprint":false},{"year":1996,"finding":"Kvβ2 selectively interacts with all five tested Kv1 (Shaker-related) alpha subunits but not with Shab- or Shaw-related subfamilies; a member of the Shal-related subfamily also interacts but with distinct biochemical characteristics. The interaction does not require the beta-subunit N-terminal domain, indicating that the conserved core mediates alpha/beta association.","method":"Transfection in mammalian cells, co-immunoprecipitation, biochemical interaction assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with multiple subunit combinations, replicated across labs","pmids":["8636142"],"is_preprint":false},{"year":1996,"finding":"The human Kvβ2 gene (KCNA2B / KCNAB2) was localized to chromosome 1p36.3 by FISH and somatic cell hybrid mapping.","method":"Fluorescence in situ hybridization (FISH) and somatic cell hybrid mapping","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 2 — direct cytogenetic localization, corroborated by YAC library PCR","pmids":["8838324"],"is_preprint":false},{"year":1999,"finding":"Kvβ2 is a component of the Kv1.1/Kv1.2 channel complex in human CNS; in cerebral grey matter, Kvβ2.1 co-associates specifically with the Kv1.1/Kv1.2 heterooligomer and Kv1.2 homooligomer, while in white matter it associates with Kv1.2 only, demonstrating region-specific complex assembly.","method":"Sequential immunoprecipitation from human brain autopsy samples, immunoblotting","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal sequential immunoprecipitation from native human tissue","pmids":["10428084"],"is_preprint":false},{"year":1999,"finding":"Caspr2 specifically associates with Kv1.1, Kv1.2, and their Kvβ2 subunit at juxtaparanodal regions of myelinated axons, with the interaction involving Caspr2's C-terminal PDZ-binding motif.","method":"Co-immunoprecipitation, immunofluorescence localization in myelinated axons","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 — direct co-IP from native tissue plus precise localization, highly cited","pmids":["10624965"],"is_preprint":false},{"year":1999,"finding":"ZIP1 and ZIP2 proteins physically link Kvβ2 to protein kinase C zeta (PKCζ), forming a ternary PKCζ–ZIP–Kv channel complex; ZIP1 and ZIP2 differentially stimulate PKCζ-mediated phosphorylation of Kvβ2 and are regulated by neurotrophic factors.","method":"Co-immunoprecipitation, in vitro phosphorylation assays, yeast two-hybrid","journal":"Science","confidence":"High","confidence_rationale":"Tier 1-2 — reconstituted complex with biochemical phosphorylation assay and multiple orthogonal methods","pmids":["10477520"],"is_preprint":false},{"year":2001,"finding":"Hemizygous deletion of KCNAB2 in 1p36 deletion syndrome patients is significantly associated with epilepsy and infantile spasms, suggesting haploinsufficiency of KCNAB2 as a risk factor for seizures via reduced K+-channel-mediated membrane repolarization.","method":"FISH-based genotyping of 24 patients correlated with clinical/EEG phenotype","journal":"Epilepsia","confidence":"Medium","confidence_rationale":"Tier 2-3 — human genetic evidence with clinical correlation, no in vitro reconstitution","pmids":["11580756"],"is_preprint":false},{"year":2002,"finding":"Kvβ2-null mice show reduced lifespan, occasional seizures, and cold swim-induced tremors; despite loss of Kvβ2, Kv1.1 and Kv1.2 localize normally at cerebellar basket cell terminals and juxtaparanodal regions, and glycosylation of Kv1.1/Kv1.2 is unaffected, ruling out a simple chaperone role. A point mutation (Y90F) abolishing AKR catalytic activity causes no overt phenotype, indicating that Kvβ2 regulates excitability through mechanisms distinct from chaperone or canonical AKR activity.","method":"Gene targeting (knockout and knock-in Y90F mice), immunohistochemistry, glycosylation analysis, behavioral phenotyping","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — genetic knockout and point mutant knock-in with multiple orthogonal readouts","pmids":["11825900"],"is_preprint":false},{"year":2003,"finding":"The T1 tetramerization domain of Kv1 channels is required for axonal targeting, and mutations in T1 that eliminate Kvβ association compromise axonal targeting of Kv1 channels, establishing that Kvβ2 interaction with the T1 domain is essential for correct axonal localization.","method":"Chimeric fusion protein expression, mutagenesis, surface expression assays in neurons","journal":"Science","confidence":"High","confidence_rationale":"Tier 2 — mutagenesis with CD4 fusion reporters and direct functional targeting assay","pmids":["12893943"],"is_preprint":false},{"year":2011,"finding":"Deletion of mouse Kcnab2 leads to deficits in associative learning and memory and increases neuronal excitability in projection neurons of the lateral amygdala, manifested as a reduction in the slow afterhyperpolarization following action potential bursts.","method":"Constitutive Kcnab2 knockout mice, behavioral assays (fear conditioning), whole-cell current-clamp electrophysiology in acute brain slices","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — KO with defined behavioral and electrophysiological phenotype using multiple readouts","pmids":["21209188"],"is_preprint":false},{"year":2020,"finding":"KCNAB2 expression positively regulates GH secretion in GH3 mammosomatotroph cells: partial knockdown of Kcnab2 reduces GH mRNA and peptide secretion, while overexpression increases both, implicating KCNAB2-modulated potassium channel activity in pituitary hormone secretion.","method":"shRNA knockdown and plasmid overexpression in GH3 cells, qPCR, ELISA","journal":"Journal of neurosurgery","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, gain- and loss-of-function in cell line with secretion assay","pmids":["32109873"],"is_preprint":false},{"year":2022,"finding":"Cell-type-specific CRISPR/Cas9 mutagenesis of Kcnab2 in dopamine neurons reduces surface expression of Kv1.2, shifts the voltage dependence of potassium channel inactivation toward more hyperpolarized potentials, broadens action potentials, reduces afterhyperpolarization, and increases spike timing irregularity and excitability — phenotypes mirrored by direct mutagenesis of the pore-forming Kv1.2 subunit.","method":"Viral-mediated CRISPR/Cas9 in adult mouse brain dopamine neurons, surface biotinylation, whole-cell patch-clamp in acute brain slices","journal":"Journal of neurophysiology","confidence":"High","confidence_rationale":"Tier 2 — somatic CRISPR KO with surface expression assay and electrophysiology, parallel Kv1.2 KO control","pmids":["35788155"],"is_preprint":false},{"year":2023,"finding":"Overexpression of KCNAB2 in NSCLC cells suppresses AKT-mTOR signaling and inhibits cell proliferation, migration, and survival in vitro and tumor growth in vivo, while CRISPR/Cas9-mediated KCNAB2 knockout augments AKT-mTOR activation and malignant behaviors.","method":"Stable overexpression and CRISPR/Cas9 KO in NSCLC cell lines, protein chip/phosphoprotein array, Western blotting, xenograft mouse model","journal":"Cell death discovery","confidence":"Medium","confidence_rationale":"Tier 2-3 — parallel gain- and loss-of-function with signaling pathway readout, single lab","pmids":["37852974"],"is_preprint":false},{"year":2025,"finding":"FTO-mediated m6A methylation of KCNAB2 mRNA suppresses KCNAB2 expression in NSCLC; FTO knockdown upregulates KCNAB2, which inhibits NSCLC cell proliferation, migration, invasion, and M2 macrophage polarization via inactivation of the PI3K/AKT pathway.","method":"m6A RNA immunoprecipitation (MeRIP), FTO knockdown, KCNAB2 overexpression, rescue experiments, CCK-8, flow cytometry, transwell assays, xenograft model","journal":"Journal of biochemical and molecular toxicology","confidence":"Medium","confidence_rationale":"Tier 2 — m6A MeRIP plus rescue experiments with multiple functional assays, single lab","pmids":["40114527"],"is_preprint":false}],"current_model":"KCNAB2 encodes Kvβ2, an aldo-keto reductase superfamily auxiliary subunit that binds the T1 domain of Kv1 (Shaker-family) alpha subunits to regulate their axonal trafficking, surface expression, and gating (shifting inactivation voltage-dependence), is phosphorylated by PKCζ via ZIP scaffold proteins, contributes to neuronal excitability and action potential repolarization in amygdala and dopamine neurons, and outside the nervous system suppresses tumor cell growth and PI3K/AKT signaling while being post-transcriptionally regulated by FTO-mediated m6A methylation."},"narrative":{"teleology":[{"year":1994,"claim":"Establishing the structural identity of Kvβ2 as an aldo-keto reductase superfamily member provided the first framework for understanding how an ion channel accessory subunit could possess enzymatic architecture, raising the question of whether catalytic activity contributes to channel regulation.","evidence":"Sequence and structural homology analysis of Kvβ2 core domain","pmids":["8001150"],"confidence":"High","gaps":["No demonstration that AKR catalytic activity is functionally relevant to channel regulation","Physiological substrate for the AKR domain unknown"]},{"year":1995,"claim":"Demonstrating that Kvβ2 directly modulates Kv1.4 inactivation kinetics in heterologous expression established it as a functional electrophysiological regulator, not merely a structural accessory.","evidence":"Heterologous co-expression of Kvβ2 with Kv1.4, two-electrode voltage clamp electrophysiology","pmids":["7649300"],"confidence":"High","gaps":["Mechanism of inactivation modulation not defined at molecular level","Native channel context not tested"]},{"year":1996,"claim":"Mapping the selectivity of Kvβ2 for all Kv1 alpha subunits and showing that the conserved core (not the N-terminus) mediates association defined the molecular rules governing alpha/beta complex assembly.","evidence":"Co-immunoprecipitation of Kvβ2 with multiple Kv subfamilies in transfected mammalian cells","pmids":["8636142"],"confidence":"High","gaps":["Stoichiometry of the alpha-beta complex not resolved","Whether the N-terminal domain has independent functions unclear"]},{"year":1999,"claim":"Identification of region-specific Kv1.1/Kv1.2/Kvβ2 complexes in human brain and their localization with Caspr2 at juxtaparanodal regions established the native channel composition and subcellular context in myelinated axons.","evidence":"Sequential immunoprecipitation from human brain autopsy tissue; co-IP and immunofluorescence in myelinated axons","pmids":["10428084","10624965"],"confidence":"High","gaps":["Functional consequence of juxtaparanodal localization for Kvβ2 specifically not tested","Whether Caspr2 interaction is direct or bridged through Kv1 alpha subunits not resolved"]},{"year":1999,"claim":"Discovery that ZIP scaffold proteins physically link Kvβ2 to PKCζ, forming a ternary signaling complex regulated by neurotrophic factors, revealed a mechanism for dynamic post-translational regulation of the channel complex.","evidence":"Co-immunoprecipitation, in vitro phosphorylation assays, and yeast two-hybrid screening","pmids":["10477520"],"confidence":"High","gaps":["Phosphorylation sites on Kvβ2 not mapped","Functional electrophysiological consequence of PKCζ-mediated phosphorylation not shown"]},{"year":2001,"claim":"Clinical association of KCNAB2 hemizygous deletion with epilepsy in 1p36 deletion syndrome patients provided the first direct human genetic evidence that Kvβ2 loss compromises seizure threshold.","evidence":"FISH genotyping of 24 1p36 deletion patients correlated with EEG and clinical seizure phenotype","pmids":["11580756"],"confidence":"Medium","gaps":["Contiguous gene deletion confounds attribution to KCNAB2 alone","No rescue or single-gene validation","Mechanism linking haploinsufficiency to seizures not demonstrated"]},{"year":2002,"claim":"Kcnab2-null mice displayed seizures and reduced lifespan yet retained normal Kv1 localization and glycosylation, while a catalytically dead Y90F knock-in showed no overt phenotype — dissociating Kvβ2's excitability role from both chaperone and AKR enzymatic functions.","evidence":"Constitutive knockout and Y90F knock-in mice with immunohistochemistry, glycosylation analysis, and behavioral phenotyping","pmids":["11825900"],"confidence":"High","gaps":["The mechanism by which Kvβ2 regulates excitability if not via chaperone or AKR activity remains unresolved","Subtle gating phenotypes in Y90F mice not comprehensively characterized"]},{"year":2003,"claim":"Showing that mutations in the Kv1 T1 domain that abolish Kvβ association also abolish axonal targeting established that Kvβ2 binding to T1 is essential for correct polarized trafficking of Kv1 channels in neurons.","evidence":"Chimeric CD4-T1 fusion constructs and T1 mutagenesis with surface expression assays in cultured neurons","pmids":["12893943"],"confidence":"High","gaps":["Adaptor or motor proteins linking the Kvβ2-T1 complex to axonal transport machinery not identified","Whether Kvβ2 versus other Kvβ isoforms are differentially required not tested"]},{"year":2011,"claim":"Kcnab2 knockout mice exhibited associative learning deficits and increased excitability in lateral amygdala projection neurons — specifically a reduced slow afterhyperpolarization — linking Kvβ2 to circuit-level function in fear memory.","evidence":"Constitutive Kcnab2 KO mice, fear conditioning, whole-cell patch-clamp in acute brain slices","pmids":["21209188"],"confidence":"High","gaps":["Contribution of specific Kv1 alpha subunit partners in amygdala not dissected","Whether learning deficit is developmental or acute not resolved"]},{"year":2022,"claim":"Cell-type-specific CRISPR mutagenesis of Kcnab2 in dopamine neurons recapitulated Kv1.2 loss-of-function phenotypes — reduced surface Kv1.2, hyperpolarized inactivation shift, broadened action potentials, and increased spike irregularity — directly demonstrating that Kvβ2 controls Kv1.2 surface expression and gating in a defined neuronal population.","evidence":"Viral CRISPR/Cas9 in adult mouse dopamine neurons, surface biotinylation, whole-cell patch-clamp in acute slices","pmids":["35788155"],"confidence":"High","gaps":["Molecular mechanism by which Kvβ2 loss reduces Kv1.2 surface expression not defined","Long-term behavioral consequences of dopamine neuron-specific loss not assessed"]},{"year":2023,"claim":"Gain- and loss-of-function experiments in NSCLC cells revealed an unexpected tumor-suppressive role for KCNAB2 through inhibition of AKT-mTOR signaling, extending its functional significance beyond excitable cells.","evidence":"Stable overexpression and CRISPR KO in NSCLC lines, phosphoprotein arrays, Western blotting, xenograft model","pmids":["37852974"],"confidence":"Medium","gaps":["Mechanism linking a potassium channel beta subunit to AKT-mTOR not elucidated","Whether the effect requires Kv1 alpha subunit interaction is untested","Single-laboratory finding not independently replicated"]},{"year":2025,"claim":"FTO-mediated m6A methylation was identified as a post-transcriptional mechanism suppressing KCNAB2 expression in NSCLC, with FTO knockdown restoring KCNAB2 and inhibiting PI3K/AKT signaling, adding an epitranscriptomic regulatory layer.","evidence":"MeRIP-qPCR, FTO knockdown, KCNAB2 rescue, functional assays, xenograft model","pmids":["40114527"],"confidence":"Medium","gaps":["Specific m6A sites on KCNAB2 mRNA not mapped at nucleotide resolution","Relevance of this regulation outside NSCLC unknown","Single-laboratory finding"]},{"year":null,"claim":"The molecular mechanism by which Kvβ2 regulates Kv1 channel surface expression and gating — given that it is neither an obligate chaperone nor dependent on AKR catalytic activity — remains the central unresolved question.","evidence":"","pmids":[],"confidence":"High","gaps":["No structural basis for how Kvβ2 promotes axonal targeting beyond T1 binding","Physiological substrate or product of the AKR domain unknown","PKCζ phosphorylation sites and their functional consequences on channel gating not defined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016491","term_label":"oxidoreductase activity","supporting_discovery_ids":[0]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,8,10,12]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[5,12]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,6]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,10,12]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[9,12]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,13]}],"complexes":["Kv1.1/Kv1.2/Kvβ2 channel complex","PKCζ–ZIP–Kvβ2 signaling complex"],"partners":["KCNA1","KCNA2","KCNA4","CNTNAP2","PRKCZ","SQSTM1","FTO"],"other_free_text":[]},"mechanistic_narrative":"KCNAB2 encodes Kvβ2, an auxiliary beta subunit of Kv1 (Shaker-family) voltage-gated potassium channels that belongs to the aldo-keto reductase superfamily yet regulates neuronal excitability through mechanisms independent of its catalytic activity [PMID:8001150, PMID:11825900]. Kvβ2 binds the T1 tetramerization domain of all Kv1 alpha subunits, forming obligate complexes (notably Kv1.1/Kv1.2/Kvβ2) that are essential for correct axonal targeting and surface expression of the channel, and it modulates inactivation gating to shape action potential repolarization and afterhyperpolarization in amygdala projection neurons and midbrain dopamine neurons [PMID:8636142, PMID:12893943, PMID:21209188, PMID:35788155]. The Kvβ2 subunit is scaffolded to PKCζ via ZIP adaptor proteins, linking channel regulation to neurotrophic signaling [PMID:10477520]. Hemizygous deletion of KCNAB2 in human 1p36 deletion syndrome is associated with epilepsy and infantile spasms, consistent with its role in membrane repolarization [PMID:11580756]."},"prefetch_data":{"uniprot":{"accession":"Q13303","full_name":"Voltage-gated potassium channel subunit beta-2","aliases":["K(+) channel subunit beta-2","Kv-beta-2","hKvbeta2"],"length_aa":367,"mass_kda":41.0,"function":"Regulatory subunit of the voltage-gated potassium (Kv) Shaker channels composed of pore-forming and potassium-conducting alpha subunits and of regulatory beta subunits (PubMed:11825900, PubMed:7649300). The beta-2/KCNAB2 cytoplasmic subunit promotes potassium channel closure via a mechanism that does not involve physical obstruction of the channel pore (PubMed:11825900, PubMed:7649300). Promotes the inactivation of Kv1.4/KCNA4 and Kv1.5/KCNA5 alpha subunit-containing channels (PubMed:11825900, PubMed:7649300). Displays nicotinamide adenine dinucleotide phosphate (NADPH)-dependent aldoketoreductase activity by catalyzing the NADPH-dependent reduction of a wide range of aldehyde and ketone substrates (By similarity). Substrate specificity includes methylglyoxal, 9,10-phenanthrenequinone, prostaglandin J2, 4-nitrobenzaldehyde, 4-nitroacetophenone and 4-oxo-trans-2-nonenal (in vitro, no physiological substrate identified yet) (By similarity). The binding of oxidized and reduced nucleotide alters Kv channel gating and may contribute to dynamic fine tuning of cell excitability (By similarity). Contributes to the regulation of nerve signaling, and prevents neuronal hyperexcitability (By similarity)","subcellular_location":"Cytoplasm; Membrane; Cell membrane; Cell projection, axon; Synapse, synaptosome; Cytoplasm, cytoskeleton","url":"https://www.uniprot.org/uniprotkb/Q13303/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNAB2","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNAB2","total_profiled":1310},"omim":[{"mim_id":"612240","title":"ATRIAL FIBRILLATION, FAMILIAL, 7; ATFB7","url":"https://www.omim.org/entry/612240"},{"mim_id":"607872","title":"CHROMOSOME 1p36 DELETION SYNDROME, DISTAL","url":"https://www.omim.org/entry/607872"},{"mim_id":"601142","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 2; KCNAB2","url":"https://www.omim.org/entry/601142"},{"mim_id":"601141","title":"POTASSIUM CHANNEL, VOLTAGE-GATED, SHAKER-RELATED SUBFAMILY, BETA MEMBER 1; KCNAB1","url":"https://www.omim.org/entry/601141"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":202.4}],"url":"https://www.proteinatlas.org/search/KCNAB2"},"hgnc":{"alias_symbol":["AKR6A5","KCNA2B","HKvbeta2.1","HKvbeta2.2"],"prev_symbol":[]},"alphafold":{"accession":"Q13303","domains":[{"cath_id":"3.20.20.100","chopping":"38-248_311-326","consensus_level":"high","plddt":98.4143,"start":38,"end":326}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13303","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q13303-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q13303-F1-predicted_aligned_error_v6.png","plddt_mean":91.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNAB2","jax_strain_url":"https://www.jax.org/strain/search?query=KCNAB2"},"sequence":{"accession":"Q13303","fasta_url":"https://rest.uniprot.org/uniprotkb/Q13303.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q13303/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q13303"}},"corpus_meta":[{"pmid":"11580756","id":"PMC_11580756","title":"Loss of the potassium channel beta-subunit gene, KCNAB2, is associated with epilepsy in patients with 1p36 deletion syndrome.","date":"2001","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/11580756","citation_count":75,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11825900","id":"PMC_11825900","title":"Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 2 (Kcnab2).","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11825900","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21209188","id":"PMC_21209188","title":"Deletion of the mouse homolog of KCNAB2, a gene linked to monosomy 1p36, results in associative memory impairments and amygdala hyperexcitability.","date":"2011","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/21209188","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8838324","id":"PMC_8838324","title":"Localization of two potassium channel beta subunit genes, KCNA1B and KCNA2B.","date":"1996","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8838324","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32109873","id":"PMC_32109873","title":"Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma.","date":"2020","source":"Journal of neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/32109873","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35788155","id":"PMC_35788155","title":"The potassium channel auxiliary subunit Kvβ2 (Kcnab2) regulates Kv1 channels and dopamine neuron firing.","date":"2022","source":"Journal of neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35788155","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40114527","id":"PMC_40114527","title":"FTO-mediated m6A Methylation of KCNAB2 Inhibits Tumor Property of Non-Small Cell Lung Cancer Cells and M2 Macrophage Polarization by Inactivating the PI3K/AKT Pathway.","date":"2025","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/40114527","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37852974","id":"PMC_37852974","title":"KCNAB2 overexpression inhibits human non-small-cell lung cancer cell growth in vitro and in vivo.","date":"2023","source":"Cell death discovery","url":"https://pubmed.ncbi.nlm.nih.gov/37852974","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10983719","id":"PMC_10983719","title":"The murine Bis1 seizure gene and the Kcnab2 gene encoding the beta2-subunit of the K+ channel are different.","date":"2000","source":"Neurogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/10983719","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.02.26.640405","title":"Distinct forms of amyloid-β moderate sleep duration through NAD<sup>+</sup>-linked redox metabolism in Alzheimer’s disease","date":"2025-03-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.26.640405","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15592455","id":"PMC_15592455","title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15592455","citation_count":916,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16713569","id":"PMC_16713569","title":"A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.","date":"2006","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16713569","citation_count":610,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10624965","id":"PMC_10624965","title":"Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels.","date":"1999","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/10624965","citation_count":429,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9760292","id":"PMC_9760292","title":"Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density.","date":"1998","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/9760292","citation_count":321,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32812023","id":"PMC_32812023","title":"Phosphorylated tau interactome in the human Alzheimer's disease brain.","date":"2020","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/32812023","citation_count":290,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24952745","id":"PMC_24952745","title":"Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization.","date":"2014","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24952745","citation_count":243,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"24332808","id":"PMC_24332808","title":"PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24332808","citation_count":204,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16710414","id":"PMC_16710414","title":"The DNA sequence and biological annotation of human chromosome 1.","date":"2006","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16710414","citation_count":144,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12893943","id":"PMC_12893943","title":"A conserved domain in axonal targeting of Kv1 (Shaker) voltage-gated potassium channels.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12893943","citation_count":136,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10428084","id":"PMC_10428084","title":"Subunit composition of Kv1 channels in human CNS.","date":"1999","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10428084","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8001150","id":"PMC_8001150","title":"Shaker K+ channel beta subunits belong to an NAD(P)H-dependent oxidoreductase superfamily.","date":"1994","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8001150","citation_count":132,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19953087","id":"PMC_19953087","title":"Comparison of substrate specificity of the ubiquitin ligases Nedd4 and Nedd4-2 using proteome arrays.","date":"2009","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/19953087","citation_count":129,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23264583","id":"PMC_23264583","title":"Genetic variation in KCNA5: impact on the atrial-specific potassium current IKur in patients with lone atrial fibrillation.","date":"2012","source":"European heart journal","url":"https://pubmed.ncbi.nlm.nih.gov/23264583","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8636142","id":"PMC_8636142","title":"Selective interaction of voltage-gated K+ channel beta-subunits with alpha-subunits.","date":"1996","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8636142","citation_count":125,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10477520","id":"PMC_10477520","title":"Differential stimulation of PKC phosphorylation of potassium channels by ZIP1 and ZIP2.","date":"1999","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/10477520","citation_count":115,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7649300","id":"PMC_7649300","title":"Alternative splicing of the human Shaker K+ channel beta 1 gene and functional expression of the beta 2 gene product.","date":"1995","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/7649300","citation_count":98,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32249768","id":"PMC_32249768","title":"FBXO22 degrades nuclear PTEN to promote tumorigenesis.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/32249768","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32814053","id":"PMC_32814053","title":"Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains.","date":"2020","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32814053","citation_count":79,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":6637,"output_tokens":1906,"usd":0.024251},"stage2":{"model":"claude-opus-4-6","input_tokens":5205,"output_tokens":1975,"usd":0.1131},"total_usd":0.360823,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":18561,"output_tokens":3330,"usd":0.052817},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7049,"output_tokens":3141,"usd":0.170655}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Kvβ2 (Kcnab2) binds to Kv1 and Kv4 family α subunits and is a member of the aldo-ketoreductase (AKR) superfamily. In Kvβ2-null mice, Kv1.1 and Kv1.2 localize normally in cerebellar basket cell terminals and juxtaparanodal regions of myelinated nerves with normal glycosylation patterns, indicating Kvβ2's chaperone-like role in Kv1 α subunit biogenesis is not required for normal localization. Mice with a Y90F point mutation abolishing AKR-like catalytic activity have no overt phenotype, indicating neither chaperone nor typical AKR catalytic activity accounts for Kvβ2's in vivo role in regulating excitability.\",\n      \"method\": \"Gene targeting (knockout and Y90F knock-in mice), immunohistochemistry, Western blot for glycosylation patterns, behavioral phenotyping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including genetic knockout, point mutant knock-in, and biochemical localization assays in a single rigorous study\",\n      \"pmids\": [\"11825900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of Kcnab2 in mice reduces the slow afterhyperpolarization (sAHP) following a burst of action potentials and increases neuronal excitability in projection neurons in the lateral nucleus of the amygdala, leading to deficits in associative learning and memory.\",\n      \"method\": \"Knockout mouse model, whole-cell current-clamp electrophysiology, behavioral assays (associative learning/memory tasks)\",\n      \"journal\": \"The Journal of neuroscience : the official journal of the Society for Neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular electrophysiological phenotype and behavioral readout using orthogonal methods\",\n      \"pmids\": [\"21209188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Kvβ2 (Kcnab2) regulates surface expression of Kv1.2 (the primary Kv1 pore-forming subunit in dopamine neurons) and shifts the voltage dependence of inactivation of potassium channel currents toward more hyperpolarized potentials. Loss of Kcnab2 broadens the action potential waveform, reduces afterhyperpolarization amplitude, and increases spike timing irregularity and excitability in spontaneously firing dopamine neurons, consistent with reduced potassium channel current.\",\n      \"method\": \"Cell-type-specific viral-mediated CRISPR/Cas9 mutagenesis in dopamine neurons, whole-cell patch-clamp electrophysiology in brain slices, surface expression assays\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific CRISPR KO with multiple orthogonal electrophysiological and trafficking readouts\",\n      \"pmids\": [\"35788155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Kcnab2 expression positively modulates GH secretion in GH3 mammosomatotroph cells: partial knockdown reduces GH mRNA and peptide secretion, while overexpression increases GH transcripts and secretion, establishing KCNAB2 as a regulator of hormone secretion in somatotroph cells.\",\n      \"method\": \"Plasmid transfection (overexpression), shRNA knockdown, qPCR, ELISA for GH peptide measurement in GH3 cell line\",\n      \"journal\": \"Journal of neurosurgery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — gain- and loss-of-function in cell line with two orthogonal readouts (mRNA and protein secretion), but single lab, cell line model\",\n      \"pmids\": [\"32109873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KCNAB2 overexpression inhibits AKT-mTOR signaling in NSCLC cells, while CRISPR/Cas9 knockout augments AKT-mTOR activation, placing KCNAB2 upstream as a negative regulator of this cascade in a cancer cell context.\",\n      \"method\": \"Exogenous overexpression, CRISPR/Cas9 knockout, protein chip (phosphoprotein) analysis, Western blot for AKT-mTOR pathway components, xenograft mouse model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — reciprocal gain/loss-of-function with pathway-level readout and in vivo validation, but single lab\",\n      \"pmids\": [\"37852974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FTO-mediated m6A methylation negatively regulates KCNAB2 expression in NSCLC cells; FTO knockdown upregulates KCNAB2, which then inhibits NSCLC cell proliferation, migration, invasion, and M2 macrophage polarization through inactivation of the PI3K/AKT pathway.\",\n      \"method\": \"m6A RNA immunoprecipitation assay, FTO knockdown, KCNAB2 overexpression, rescue experiments, Western blot for PI3K/AKT pathway, cell-based functional assays, xenograft model\",\n      \"journal\": \"Journal of biochemical and molecular toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — m6A RIP assay establishes the writer-substrate relationship; rescue experiments and pathway readouts provide mechanistic support, single lab\",\n      \"pmids\": [\"40114527\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The human Kvβ2 gene (KCNAB2/KCNA2B) was localized by FISH and somatic cell hybrid mapping to chromosome 1p36.3.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH), somatic cell hybrid mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct cytogenetic localization using two independent methods\",\n      \"pmids\": [\"8838324\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNAB2 encodes the voltage-gated potassium channel auxiliary subunit Kvβ2, a member of the aldo-ketoreductase superfamily that associates with Kv1 (and Kv4) α subunits to regulate their surface expression, voltage-dependence of inactivation, and membrane repolarization; in neurons it modulates afterhyperpolarization and excitability (with loss causing hyperexcitability, seizures, and memory deficits), while in non-neuronal contexts it negatively regulates the PI3K/AKT/mTOR pathway and is itself regulated by FTO-mediated m6A methylation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1994,\n      \"finding\": \"Kvβ2 (KCNAB2) belongs to the NAD(P)H-dependent oxidoreductase (aldo-keto reductase, AKR) superfamily, establishing that the beta subunit core domain has structural homology to oxidoreductases.\",\n      \"method\": \"Sequence analysis and structural homology\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — foundational sequence/structural analysis, highly cited, widely accepted\",\n      \"pmids\": [\"8001150\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1995,\n      \"finding\": \"Kvβ2 (KCNAB2) modulates the inactivation properties of Kv1.4 alpha subunits in functional expression assays, demonstrating a direct electrophysiological role for the beta 2 subunit.\",\n      \"method\": \"Heterologous expression and electrophysiology\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — direct functional electrophysiology in expression system, replicated in subsequent studies\",\n      \"pmids\": [\"7649300\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"Kvβ2 selectively interacts with all five tested Kv1 (Shaker-related) alpha subunits but not with Shab- or Shaw-related subfamilies; a member of the Shal-related subfamily also interacts but with distinct biochemical characteristics. The interaction does not require the beta-subunit N-terminal domain, indicating that the conserved core mediates alpha/beta association.\",\n      \"method\": \"Transfection in mammalian cells, co-immunoprecipitation, biochemical interaction assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with multiple subunit combinations, replicated across labs\",\n      \"pmids\": [\"8636142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"The human Kvβ2 gene (KCNA2B / KCNAB2) was localized to chromosome 1p36.3 by FISH and somatic cell hybrid mapping.\",\n      \"method\": \"Fluorescence in situ hybridization (FISH) and somatic cell hybrid mapping\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct cytogenetic localization, corroborated by YAC library PCR\",\n      \"pmids\": [\"8838324\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Kvβ2 is a component of the Kv1.1/Kv1.2 channel complex in human CNS; in cerebral grey matter, Kvβ2.1 co-associates specifically with the Kv1.1/Kv1.2 heterooligomer and Kv1.2 homooligomer, while in white matter it associates with Kv1.2 only, demonstrating region-specific complex assembly.\",\n      \"method\": \"Sequential immunoprecipitation from human brain autopsy samples, immunoblotting\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal sequential immunoprecipitation from native human tissue\",\n      \"pmids\": [\"10428084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Caspr2 specifically associates with Kv1.1, Kv1.2, and their Kvβ2 subunit at juxtaparanodal regions of myelinated axons, with the interaction involving Caspr2's C-terminal PDZ-binding motif.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence localization in myelinated axons\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct co-IP from native tissue plus precise localization, highly cited\",\n      \"pmids\": [\"10624965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"ZIP1 and ZIP2 proteins physically link Kvβ2 to protein kinase C zeta (PKCζ), forming a ternary PKCζ–ZIP–Kv channel complex; ZIP1 and ZIP2 differentially stimulate PKCζ-mediated phosphorylation of Kvβ2 and are regulated by neurotrophic factors.\",\n      \"method\": \"Co-immunoprecipitation, in vitro phosphorylation assays, yeast two-hybrid\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — reconstituted complex with biochemical phosphorylation assay and multiple orthogonal methods\",\n      \"pmids\": [\"10477520\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Hemizygous deletion of KCNAB2 in 1p36 deletion syndrome patients is significantly associated with epilepsy and infantile spasms, suggesting haploinsufficiency of KCNAB2 as a risk factor for seizures via reduced K+-channel-mediated membrane repolarization.\",\n      \"method\": \"FISH-based genotyping of 24 patients correlated with clinical/EEG phenotype\",\n      \"journal\": \"Epilepsia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — human genetic evidence with clinical correlation, no in vitro reconstitution\",\n      \"pmids\": [\"11580756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Kvβ2-null mice show reduced lifespan, occasional seizures, and cold swim-induced tremors; despite loss of Kvβ2, Kv1.1 and Kv1.2 localize normally at cerebellar basket cell terminals and juxtaparanodal regions, and glycosylation of Kv1.1/Kv1.2 is unaffected, ruling out a simple chaperone role. A point mutation (Y90F) abolishing AKR catalytic activity causes no overt phenotype, indicating that Kvβ2 regulates excitability through mechanisms distinct from chaperone or canonical AKR activity.\",\n      \"method\": \"Gene targeting (knockout and knock-in Y90F mice), immunohistochemistry, glycosylation analysis, behavioral phenotyping\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout and point mutant knock-in with multiple orthogonal readouts\",\n      \"pmids\": [\"11825900\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The T1 tetramerization domain of Kv1 channels is required for axonal targeting, and mutations in T1 that eliminate Kvβ association compromise axonal targeting of Kv1 channels, establishing that Kvβ2 interaction with the T1 domain is essential for correct axonal localization.\",\n      \"method\": \"Chimeric fusion protein expression, mutagenesis, surface expression assays in neurons\",\n      \"journal\": \"Science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mutagenesis with CD4 fusion reporters and direct functional targeting assay\",\n      \"pmids\": [\"12893943\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of mouse Kcnab2 leads to deficits in associative learning and memory and increases neuronal excitability in projection neurons of the lateral amygdala, manifested as a reduction in the slow afterhyperpolarization following action potential bursts.\",\n      \"method\": \"Constitutive Kcnab2 knockout mice, behavioral assays (fear conditioning), whole-cell current-clamp electrophysiology in acute brain slices\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined behavioral and electrophysiological phenotype using multiple readouts\",\n      \"pmids\": [\"21209188\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KCNAB2 expression positively regulates GH secretion in GH3 mammosomatotroph cells: partial knockdown of Kcnab2 reduces GH mRNA and peptide secretion, while overexpression increases both, implicating KCNAB2-modulated potassium channel activity in pituitary hormone secretion.\",\n      \"method\": \"shRNA knockdown and plasmid overexpression in GH3 cells, qPCR, ELISA\",\n      \"journal\": \"Journal of neurosurgery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, gain- and loss-of-function in cell line with secretion assay\",\n      \"pmids\": [\"32109873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Cell-type-specific CRISPR/Cas9 mutagenesis of Kcnab2 in dopamine neurons reduces surface expression of Kv1.2, shifts the voltage dependence of potassium channel inactivation toward more hyperpolarized potentials, broadens action potentials, reduces afterhyperpolarization, and increases spike timing irregularity and excitability — phenotypes mirrored by direct mutagenesis of the pore-forming Kv1.2 subunit.\",\n      \"method\": \"Viral-mediated CRISPR/Cas9 in adult mouse brain dopamine neurons, surface biotinylation, whole-cell patch-clamp in acute brain slices\",\n      \"journal\": \"Journal of neurophysiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — somatic CRISPR KO with surface expression assay and electrophysiology, parallel Kv1.2 KO control\",\n      \"pmids\": [\"35788155\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Overexpression of KCNAB2 in NSCLC cells suppresses AKT-mTOR signaling and inhibits cell proliferation, migration, and survival in vitro and tumor growth in vivo, while CRISPR/Cas9-mediated KCNAB2 knockout augments AKT-mTOR activation and malignant behaviors.\",\n      \"method\": \"Stable overexpression and CRISPR/Cas9 KO in NSCLC cell lines, protein chip/phosphoprotein array, Western blotting, xenograft mouse model\",\n      \"journal\": \"Cell death discovery\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — parallel gain- and loss-of-function with signaling pathway readout, single lab\",\n      \"pmids\": [\"37852974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FTO-mediated m6A methylation of KCNAB2 mRNA suppresses KCNAB2 expression in NSCLC; FTO knockdown upregulates KCNAB2, which inhibits NSCLC cell proliferation, migration, invasion, and M2 macrophage polarization via inactivation of the PI3K/AKT pathway.\",\n      \"method\": \"m6A RNA immunoprecipitation (MeRIP), FTO knockdown, KCNAB2 overexpression, rescue experiments, CCK-8, flow cytometry, transwell assays, xenograft model\",\n      \"journal\": \"Journal of biochemical and molecular toxicology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — m6A MeRIP plus rescue experiments with multiple functional assays, single lab\",\n      \"pmids\": [\"40114527\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNAB2 encodes Kvβ2, an aldo-keto reductase superfamily auxiliary subunit that binds the T1 domain of Kv1 (Shaker-family) alpha subunits to regulate their axonal trafficking, surface expression, and gating (shifting inactivation voltage-dependence), is phosphorylated by PKCζ via ZIP scaffold proteins, contributes to neuronal excitability and action potential repolarization in amygdala and dopamine neurons, and outside the nervous system suppresses tumor cell growth and PI3K/AKT signaling while being post-transcriptionally regulated by FTO-mediated m6A methylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNAB2 encodes Kvβ2, a voltage-gated potassium channel auxiliary subunit of the aldo-keto reductase (AKR) superfamily that associates with Kv1 and Kv4 family α subunits to regulate their surface expression and voltage-dependent inactivation [PMID:11825900, PMID:35788155]. In neurons, Kvβ2 promotes surface expression of Kv1.2, shifts inactivation gating toward hyperpolarized potentials, and sustains the slow afterhyperpolarization; its loss broadens action potentials, increases neuronal excitability, and impairs associative learning and memory [PMID:21209188, PMID:35788155]. Notably, the AKR catalytic activity of Kvβ2 is dispensable for its in vivo effects on excitability, and its chaperone-like role is not required for normal Kv1 α-subunit localization in myelinated nerves or cerebellar terminals [PMID:11825900]. In non-neuronal contexts, KCNAB2 functions as a negative regulator of the PI3K/AKT/mTOR signaling cascade, and its expression is itself regulated by FTO-mediated m6A RNA methylation [PMID:37852974, PMID:40114527].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapping KCNAB2 to chromosome 1p36.3 established the genomic locus for the human Kvβ2 gene, enabling future genotype-phenotype studies.\",\n      \"evidence\": \"FISH and somatic cell hybrid mapping in human cells\",\n      \"pmids\": [\"8838324\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No functional characterization accompanied the mapping\",\n        \"Potential association with 1p36 deletion syndrome not investigated\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Knockout and catalytic-dead knock-in mice demonstrated that neither Kvβ2's chaperone-like activity for Kv1 α-subunit trafficking nor its AKR enzymatic activity accounts for its in vivo role in regulating neuronal excitability, leaving the core mechanism unresolved.\",\n      \"evidence\": \"Kcnab2-null and Y90F knock-in mice with immunohistochemistry, glycosylation assays, and behavioral phenotyping\",\n      \"pmids\": [\"11825900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The molecular mechanism through which Kvβ2 regulates excitability independent of AKR catalysis and α-subunit trafficking remains unknown\",\n        \"Electrophysiological characterization of knockout neurons was not performed in this study\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Electrophysiology in Kcnab2-null amygdala neurons revealed that Kvβ2 sustains the slow afterhyperpolarization and restrains neuronal excitability, linking the channel subunit to associative learning and memory at the behavioral level.\",\n      \"evidence\": \"Whole-cell current-clamp recordings in lateral amygdala neurons of knockout mice combined with behavioral memory assays\",\n      \"pmids\": [\"21209188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether the sAHP reduction results from altered Kv1 surface expression or gating was not distinguished\",\n        \"Contribution of other Kvβ isoforms to compensation was not assessed\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cell-type-specific CRISPR deletion in dopamine neurons established that Kvβ2 promotes Kv1.2 surface expression and shifts inactivation gating, providing a biophysical mechanism for the excitability phenotype observed in knockouts.\",\n      \"evidence\": \"Viral CRISPR/Cas9 mutagenesis in dopamine neurons with patch-clamp electrophysiology and surface expression assays in brain slices\",\n      \"pmids\": [\"35788155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for how Kvβ2 promotes Kv1.2 surface expression is not defined\",\n        \"Whether the gating shift is direct or involves auxiliary proteins is unclear\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Reciprocal gain- and loss-of-function experiments in NSCLC cells revealed an unexpected non-channel role for KCNAB2 as a negative regulator of AKT-mTOR signaling, extending its functional repertoire beyond ion channel modulation.\",\n      \"evidence\": \"Overexpression and CRISPR knockout in NSCLC cell lines with phosphoprotein arrays, Western blot, and xenograft models\",\n      \"pmids\": [\"37852974\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"The direct molecular target linking Kvβ2 to AKT-mTOR inhibition is unidentified\",\n        \"Whether this function requires potassium channel association is untested\",\n        \"Single-lab finding awaiting independent replication\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"FTO-mediated m6A demethylation was shown to suppress KCNAB2 expression, placing epitranscriptomic regulation upstream of the KCNAB2–PI3K/AKT axis in NSCLC.\",\n      \"evidence\": \"m6A RIP, FTO knockdown, KCNAB2 overexpression rescue, PI3K/AKT Western blot, and xenograft validation\",\n      \"pmids\": [\"40114527\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Precise m6A site(s) on KCNAB2 mRNA mediating the effect are not mapped\",\n        \"Whether FTO regulation of KCNAB2 occurs in neurons or other tissues is unknown\",\n        \"Single-lab finding awaiting independent replication\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which Kvβ2 sustains the afterhyperpolarization — independent of its AKR catalytic activity and apparently beyond simple trafficking of Kv1 α subunits — remains the central unresolved question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No structural model of the Kvβ2-dependent gating modulation exists\",\n        \"Whether the non-channel PI3K/AKT regulatory function is physiologically relevant outside cancer cells is untested\",\n        \"Endogenous AKR substrates of Kvβ2, if any, have not been identified in vivo\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 2]},\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 2]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [4, 5]}\n    ],\n    \"complexes\": [\n      \"Kv1 potassium channel complex\"\n    ],\n    \"partners\": [\n      \"KCNA1\",\n      \"KCNA2\",\n      \"FTO\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"KCNAB2 encodes Kvβ2, an auxiliary beta subunit of Kv1 (Shaker-family) voltage-gated potassium channels that belongs to the aldo-keto reductase superfamily yet regulates neuronal excitability through mechanisms independent of its catalytic activity [PMID:8001150, PMID:11825900]. Kvβ2 binds the T1 tetramerization domain of all Kv1 alpha subunits, forming obligate complexes (notably Kv1.1/Kv1.2/Kvβ2) that are essential for correct axonal targeting and surface expression of the channel, and it modulates inactivation gating to shape action potential repolarization and afterhyperpolarization in amygdala projection neurons and midbrain dopamine neurons [PMID:8636142, PMID:12893943, PMID:21209188, PMID:35788155]. The Kvβ2 subunit is scaffolded to PKCζ via ZIP adaptor proteins, linking channel regulation to neurotrophic signaling [PMID:10477520]. Hemizygous deletion of KCNAB2 in human 1p36 deletion syndrome is associated with epilepsy and infantile spasms, consistent with its role in membrane repolarization [PMID:11580756].\",\n  \"teleology\": [\n    {\n      \"year\": 1994,\n      \"claim\": \"Establishing the structural identity of Kvβ2 as an aldo-keto reductase superfamily member provided the first framework for understanding how an ion channel accessory subunit could possess enzymatic architecture, raising the question of whether catalytic activity contributes to channel regulation.\",\n      \"evidence\": \"Sequence and structural homology analysis of Kvβ2 core domain\",\n      \"pmids\": [\"8001150\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No demonstration that AKR catalytic activity is functionally relevant to channel regulation\", \"Physiological substrate for the AKR domain unknown\"]\n    },\n    {\n      \"year\": 1995,\n      \"claim\": \"Demonstrating that Kvβ2 directly modulates Kv1.4 inactivation kinetics in heterologous expression established it as a functional electrophysiological regulator, not merely a structural accessory.\",\n      \"evidence\": \"Heterologous co-expression of Kvβ2 with Kv1.4, two-electrode voltage clamp electrophysiology\",\n      \"pmids\": [\"7649300\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of inactivation modulation not defined at molecular level\", \"Native channel context not tested\"]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Mapping the selectivity of Kvβ2 for all Kv1 alpha subunits and showing that the conserved core (not the N-terminus) mediates association defined the molecular rules governing alpha/beta complex assembly.\",\n      \"evidence\": \"Co-immunoprecipitation of Kvβ2 with multiple Kv subfamilies in transfected mammalian cells\",\n      \"pmids\": [\"8636142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of the alpha-beta complex not resolved\", \"Whether the N-terminal domain has independent functions unclear\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identification of region-specific Kv1.1/Kv1.2/Kvβ2 complexes in human brain and their localization with Caspr2 at juxtaparanodal regions established the native channel composition and subcellular context in myelinated axons.\",\n      \"evidence\": \"Sequential immunoprecipitation from human brain autopsy tissue; co-IP and immunofluorescence in myelinated axons\",\n      \"pmids\": [\"10428084\", \"10624965\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of juxtaparanodal localization for Kvβ2 specifically not tested\", \"Whether Caspr2 interaction is direct or bridged through Kv1 alpha subunits not resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Discovery that ZIP scaffold proteins physically link Kvβ2 to PKCζ, forming a ternary signaling complex regulated by neurotrophic factors, revealed a mechanism for dynamic post-translational regulation of the channel complex.\",\n      \"evidence\": \"Co-immunoprecipitation, in vitro phosphorylation assays, and yeast two-hybrid screening\",\n      \"pmids\": [\"10477520\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Phosphorylation sites on Kvβ2 not mapped\", \"Functional electrophysiological consequence of PKCζ-mediated phosphorylation not shown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Clinical association of KCNAB2 hemizygous deletion with epilepsy in 1p36 deletion syndrome patients provided the first direct human genetic evidence that Kvβ2 loss compromises seizure threshold.\",\n      \"evidence\": \"FISH genotyping of 24 1p36 deletion patients correlated with EEG and clinical seizure phenotype\",\n      \"pmids\": [\"11580756\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Contiguous gene deletion confounds attribution to KCNAB2 alone\", \"No rescue or single-gene validation\", \"Mechanism linking haploinsufficiency to seizures not demonstrated\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Kcnab2-null mice displayed seizures and reduced lifespan yet retained normal Kv1 localization and glycosylation, while a catalytically dead Y90F knock-in showed no overt phenotype — dissociating Kvβ2's excitability role from both chaperone and AKR enzymatic functions.\",\n      \"evidence\": \"Constitutive knockout and Y90F knock-in mice with immunohistochemistry, glycosylation analysis, and behavioral phenotyping\",\n      \"pmids\": [\"11825900\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"The mechanism by which Kvβ2 regulates excitability if not via chaperone or AKR activity remains unresolved\", \"Subtle gating phenotypes in Y90F mice not comprehensively characterized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Showing that mutations in the Kv1 T1 domain that abolish Kvβ association also abolish axonal targeting established that Kvβ2 binding to T1 is essential for correct polarized trafficking of Kv1 channels in neurons.\",\n      \"evidence\": \"Chimeric CD4-T1 fusion constructs and T1 mutagenesis with surface expression assays in cultured neurons\",\n      \"pmids\": [\"12893943\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Adaptor or motor proteins linking the Kvβ2-T1 complex to axonal transport machinery not identified\", \"Whether Kvβ2 versus other Kvβ isoforms are differentially required not tested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Kcnab2 knockout mice exhibited associative learning deficits and increased excitability in lateral amygdala projection neurons — specifically a reduced slow afterhyperpolarization — linking Kvβ2 to circuit-level function in fear memory.\",\n      \"evidence\": \"Constitutive Kcnab2 KO mice, fear conditioning, whole-cell patch-clamp in acute brain slices\",\n      \"pmids\": [\"21209188\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of specific Kv1 alpha subunit partners in amygdala not dissected\", \"Whether learning deficit is developmental or acute not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Cell-type-specific CRISPR mutagenesis of Kcnab2 in dopamine neurons recapitulated Kv1.2 loss-of-function phenotypes — reduced surface Kv1.2, hyperpolarized inactivation shift, broadened action potentials, and increased spike irregularity — directly demonstrating that Kvβ2 controls Kv1.2 surface expression and gating in a defined neuronal population.\",\n      \"evidence\": \"Viral CRISPR/Cas9 in adult mouse dopamine neurons, surface biotinylation, whole-cell patch-clamp in acute slices\",\n      \"pmids\": [\"35788155\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which Kvβ2 loss reduces Kv1.2 surface expression not defined\", \"Long-term behavioral consequences of dopamine neuron-specific loss not assessed\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Gain- and loss-of-function experiments in NSCLC cells revealed an unexpected tumor-suppressive role for KCNAB2 through inhibition of AKT-mTOR signaling, extending its functional significance beyond excitable cells.\",\n      \"evidence\": \"Stable overexpression and CRISPR KO in NSCLC lines, phosphoprotein arrays, Western blotting, xenograft model\",\n      \"pmids\": [\"37852974\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism linking a potassium channel beta subunit to AKT-mTOR not elucidated\", \"Whether the effect requires Kv1 alpha subunit interaction is untested\", \"Single-laboratory finding not independently replicated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"FTO-mediated m6A methylation was identified as a post-transcriptional mechanism suppressing KCNAB2 expression in NSCLC, with FTO knockdown restoring KCNAB2 and inhibiting PI3K/AKT signaling, adding an epitranscriptomic regulatory layer.\",\n      \"evidence\": \"MeRIP-qPCR, FTO knockdown, KCNAB2 rescue, functional assays, xenograft model\",\n      \"pmids\": [\"40114527\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific m6A sites on KCNAB2 mRNA not mapped at nucleotide resolution\", \"Relevance of this regulation outside NSCLC unknown\", \"Single-laboratory finding\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The molecular mechanism by which Kvβ2 regulates Kv1 channel surface expression and gating — given that it is neither an obligate chaperone nor dependent on AKR catalytic activity — remains the central unresolved question.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No structural basis for how Kvβ2 promotes axonal targeting beyond T1 binding\", \"Physiological substrate or product of the AKR domain unknown\", \"PKCζ phosphorylation sites and their functional consequences on channel gating not defined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016491\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 8, 10, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [5, 12]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 10, 12]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [9, 12]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 13]}\n    ],\n    \"complexes\": [\n      \"Kv1.1/Kv1.2/Kvβ2 channel complex\",\n      \"PKCζ–ZIP–Kvβ2 signaling complex\"\n    ],\n    \"partners\": [\n      \"KCNA1\",\n      \"KCNA2\",\n      \"KCNA4\",\n      \"CNTNAP2\",\n      \"PRKCZ\",\n      \"SQSTM1\",\n      \"FTO\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}